Sanofi (Euronext: SAN; NYSE: SNY) announced today that it received FDA approval for its Toujeo Max SoloStar insulin pen, the highest capacity long-acting insulin pen that will be available on the ...

The "Insulin Pens Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The insulin pens market is expected to grow at a CAGR of 6.26% during the ...

Ahead of World Diabetes Day, Doctors Without Borders/Médecins Sans Frontières (MSF) called for all insulin manufacturers to provide injection pen devices at $1 per pen. The humanitarian organization ...

Medtronic. Dexcom. Abbott. Sanofi. Google. A lot of very large, well-known companies are investing heavily into innovating the diabetes space, and that innovation is exciting. But a disproportionate ...

Rising Diabetes Drives Technological Advancements in North America Insulin Pen Market: Shift to Self-Care and Home-Based ...

Common Sensing, a Cambridge-based company developing a smart connected insulin pen cap, announced that it will test its device in a clinical trial in collaboration with Joslin Diabetes Center, Sanofi, ...

MUMBAI, Nov 29 (Reuters) - French drugmaker Sanofi-Aventis plans to launch reusable insulin pens in India in the second quarter of 2011, a senior official said on Monday. "This is an Indianised device ...

As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood sugar control in people with diabetes. The approval is for a 3 milliliter (mL) single-patient-use prefilled ...

The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering. The Japan Insulin Pen Market is forecasted to rise from US$ 304.26 Million in 2024 to US$ ...

NEW YORK (Reuters) - Sanofi SA said on Wednesday it will cut the cost of its insulin products to $99 per month for uninsured patients and others who pay cash for it in the United States, as the French ...

More Americans with diabetes will get a break on their insulin costs in 2024. Sanofi is joining the nation's two other major insulin manufacturers in offering either price caps or savings programs ...